Orthofix International | OFIX - Des Atouts





Des Atouts Changement Date
Accuray USD 448.01M 8.81M 2025-12
AngioDynamics USD 269.68M 4.04M 2025-09
Artivion USD 1.07B 188.78M 2026-06
AtriCure USD 717.54M 40.89M 2026-09
Dexcom USD 6.24B 216.5M 2026-09
EDAP TMS EUR 72.06M 10.6M 2026-03
Globus Medical USD 5.49B 48.7M 2026-06
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 3.42B 250M 2026-09
Integra LifeSciences USD 3.51B 55.69M 2026-09
J&J USD 197.42B 3.64B 2026-09
Medtronic USD 93.31B 278M 2026-06
Mesa Laboratories USD 434.85M 4.5M 2025-12
Orthofix International USD 873.02M 13.58M 2026-06
Plus Therapeutics USD 14.03M 5.89M 2026-06
Smith & Nephew USD 11.01B 321M 2026-06
STAAR Surgical USD 485.16M 9.95M 2026-09
Stryker USD 47.25B 683M 2026-09
Tandem Diabetes Care USD 1.15B 808K 2026-06
Teleflex USD 6.79B 3.78M 2026-06
Veracyte USD 1.57B 86.89M 2026-09
Zimmer Biomet Holdings USD 23.54B 740.8M 2026-09